𝔖 Bobbio Scriptorium
✦   LIBER   ✦

5-fluorouracil and isoprinosine in the treatment of advanced colorectal cancer. A limited phase I, II evaluation

✍ Scribed by Mariantonietta Colozza; Maurizio Tonato; Virginio Belsanti; Anna Maria Mosconi; Stefano Fiorucci; Ivano Gernini; Pietro Rambotti; Stephen Davis

Publisher
John Wiley and Sons
Year
1988
Tongue
English
Weight
440 KB
Volume
62
Category
Article
ISSN
0008-543X

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

A phase III trial of 5-fluorouracil and
A phase III trial of 5-fluorouracil and leucovorin in the treatment of advanced colorectal cancer. A mayo clinic/north central cancer treatment group study
✍ Michael J. O'Connell πŸ“‚ Article πŸ“… 1989 πŸ› John Wiley and Sons 🌐 English βš– 498 KB πŸ‘ 2 views

The Mayo Clinic and the North Central Cancer Treatment Group (NCCTG) conducted a randomized clinical trial comparing five different combination chemotherapeutic regimens to single-agent 5-fluorouracil (5-FU), given by intravenous bolus technique (500 mg/m2 for 5 days) as a control, in the treatment

A phase II study of combined 5-fluoroura
A phase II study of combined 5-fluorouracil and mitomycin C in advanced breast cancer
✍ Willy Mattsson; Finn Von Eyben; Lennart Hallsten; GΓΆran Bjelkengren πŸ“‚ Article πŸ“… 1982 πŸ› John Wiley and Sons 🌐 English βš– 340 KB πŸ‘ 1 views

In a Phase I1 study, 50 patients with advanced breast cancer were treated with a combination of 5fluorouracil(lOO0 mg/m2 on days 1 and 2) and mitomycin C (6 mg/m2 on day 2) (FuMi regimen). The courses were repeated every third to sixth week. Although 35 patients had previously received combination c